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Abstract
Selenoproteins exhibit diverse biological functions, most of which are associated with redox control. However, the functions
of approximately half of mammalian selenoproteins are not known. One such protein is Selenoprotein O (SelO), the largest
mammalian selenoprotein with orthologs found in a wide range of organisms, including bacteria and yeast. Here, we report
characterization of mammalian SelO. Expression of this protein could be verified in HEK 293T cells by metabolic labeling of
cells with 75Se, and it was abolished when selenocysteine was replaced with serine. A CxxU motif was identified in the C-
terminal region of SelO. This protein was reversibly oxidized in a time- and concentration-dependent manner in HEK 293T
cells when cells were treated with hydrogen peroxide. This treatment led to the formation of a transient 88 kDa SelO-
containing complex. The formation of this complex was enhanced by replacing the CxxU motif with SxxC, but abolished
when it was replaced with SxxS, suggesting a redox interaction of SelO with another protein through its Sec residue. SelO
was localized to mitochondria and expressed across mouse tissues. Its expression was little affected by selenium deficiency,
suggesting it has a high priority for selenium supply. Taken together, these results show that SelO is a redox-active
mitochondrial selenoprotein.
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Introduction
Selenium is an essential trace element that supports biological
functions by being a component of selenocysteine (Sec), the 21st
proteinogenic amino acid [1,2,3]. The synthesis of Sec-containing
proteins (selenoproteins) involves a unique mechanism to co-
translationally incorporate Sec into a growing peptide chain. In
particular, Sec insertion sequence (SECIS) element in the 39-
untranslated region (39-UTR) in eukaryotes is necessary for
recruitment of tRNASec to insert Sec in response to UGA codon
[4,5,6]. A combination of SECIS elements and in-frame UGA
codons has been adopted for in silico characterization of seleno-
proteomes (full sets of selenoproteins) in diverse organisms [6,7,8].
Twenty five selenoprotein genes have been identified in humans
via this in silico approach and further verified experimentally [6].
Following identification of selenoproteins, their biological
functions have been studied extensively. Interestingly, most
functionally characterized selenoproteins are oxidoreductases that
participate in various redox processes such as antioxidant defense,
redox regulation of biological functions, redox signaling, and many
other oxidoreductase reactions [9–13]. Sec supports a higher
catalytic efficiency than Cys owing to its higher polarizability and
lower pKa (,5.2) value, and perhaps due to other properties
[14,15]. Being a superior catalyst, it is not surprising that Sec may
replace catalytic Cys in thiol oxidoreductases [16–18].
Up to date, functions have been characterized for approxi-
mately half of mammalian selenoproteins. SelO is the largest
protein among the 25 mammalian selenoproteins and has been
hypothesized to have a kinase domain [19,20]. In the present
study, we characterized human SelO with regard to localization,
Sec incorporation, redox interactions and regulation by dietary
selenium status.
Materials and Methods
Cells, Tissues and Transfection
Human embryonic kidney (HEK) 293T cells were maintained
with Dulbecco’s modified Eagle’s medium (DMEM) supplemented
10% fetal bovine serum (FBS) or bovine calf serum (BCS;
Hyclone, UT, USA) and antibiotics (1% penicillin and strepto-
mycin; Invitrogen, Carlsbad, CA, USA) humidified air containing
5% CO2 at 37uC. Cells were transfected with SelO mutant
constructs using calcium phosphate transfection methods. Twenty
four hours after transfection, cells were washed and treated with
hydrogen peroxides (H2O2) at various concentrations and times
indicated.
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Selenium Diet Study
Three-week old C57BL/6 male mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). After a week of acclima-
tion, the mice were randomly divided into four groups (n = 5
animals per group) and selenium diets for 8 weeks. These diets
were purchased from Harland Teklad (Madison, MI) and varied in
selenium levels, i.e., 0, 0.1, 0.4, and 2.25 ppm. Animals were
euthanized at the age of 12 weeks and their tissues were harvested
and immediately frozen in liquid nitrogen until further use. All
animal experiments were approved by the Brigham and Women’s
Hospital and Harvard Medical School Institutional Animal Care
and Use Committee.
Specific SelO Antibody
Polyclonal antiserum against human SelO was raised in rabbits.
Rabbits were immunized with KLH-conjugated synthetic peptide
containing the deduced amino acids C-642ADGADGRQR-
SYSSKPPL658-NH2. Cysteine was appended at the N-terminus
for KLH conjugation. Anti-SelO IgG was purified by affinity
chromatography using an affinity matrix linked with the antigen
peptide. Both the synthetic peptide and affinity gel matrix column
were manufactured by Peptron (Daejeon, Korea). Purified anti-
SelO was eluted with 100 mM glycine (pH 2.5) and the antibody
fractions were neutralized in 1 M Tris-HCl (pH 8.0) buffer.
Constructs and Polymerase Chain Reaction (PCR)
Human SelO cDNA was purchased as cDNA clone (IMAGE
ID: 6041782) from imaGenes (Berlin, Germany). cDNA was
amplified from EconoTaq PLUS GREEN 2X Master Mix
(Lucigen, Middleton, WI, USA) with 5% volumes of dimethyl
sulfoxide (Sigma, St. Louis, MO, USA). The pCI-Toxo-SECIS
vector contains a highly efficient Toxoplasma gondii SelT SECIS
element [21]. SelO MLS sequence was cloned into the Nhe1/
EcoR1 restriction sites of the pCI-SelK-Toxo-SECIS vector
modified from the pCI-neo (Promega, Madison, WI, USA) [22].
We cloned the SelO open reading frame (ORF) and then replaced
the SelK ORF in XbaI/SalI restriction sites. Primer sequences are
shown in the Table S1. Primer pairs 1 and 2 were used and
digested with NheI/EcoRI restriction enzymes to prepare the first
MLS cloned into pCI SelK-Toxo-SECIS constructs. The forward
primer 3 and the reverse 4–9 primers were used and digested with
XbaI/SalI to prepare SelO constructs. To investigate the
subcellular localization of SelO, we cloned SelO ORF into
pEGFPN1 vector with NheI//SalI restriction sites. Sequences of
constructs were verified by sequencing at Genewiz (Boston, MA,
USA).
75Se Metabolic Labeling and Identifying Human SelO
HEK293T cells were metabolically labeled with 75Se for 40 h.
The cells were lysed in 0.1% NP40 cell lysis buffer (20 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 5% Glycerol) containing protease
inhibitor (Roche Applied Science, Indianapolis, IN, USA) and
20 mM N-ethylmaleimide. The cell lysates were sonicated for
15 min and centrifuged at 13,000 rpm for 10 min at 4uC. The
supernatants were precleared with 30 ml of 50% slurry of Protein
A/G agarose (SantaCruz Biotechnology, CA, USA) for 1 h. The
precleared samples were incubated with 10 ml of anti-SelO
antibody for 2 h. Then 30 ml of 50% slurry Protein A/G agarose
was added and incubated for 2 h at 4uC. The beads were washed
five times with lysis buffer (0.1% NP40, 20 mM Tris-HCl, pH 7.4,
and 150 mM NaCl). Bound proteins were eluted with 1x LDS
sample buffer (Invitrogen) by boiling for 10 min at 70uC. The
samples were electrophoresed on 10% Bis-Tris Gels (Invitrogen)
and transferred to PVDF membranes. 75Se radioactivity was
visualized by using a Phosphorimager system (GE Healthcare,
Parsippany, NJ, USA).
Affinity Purification
For affinity purification, HA-TEV tagged SelO and their
binding proteins were expressed in HEK293T cells, and lysed in
0.1% NP40 lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 5% Glycerol) containing a protease inhibitor and 20 mM
Figure 1. Mitochondrial localization of human SelO. (A) Schematics of recombinant SelO. It contains the mitochondrial leader sequence (MLS)
at the N-terminus and the green fluorescent protein (GFP) at the C-terminus. Sec was changed to Cys. (B) Western blotting of SelO, TR2, tubulin, and
TR1 in two separate fractions, cytosolic and mitochondrial, isolated from HEK293T cells. (C) Mitochondrial localization of recombinant SelO. The EGFP
signal is shown in green and Mito-Tracker in red.
doi:10.1371/journal.pone.0095518.g001
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NEM. The cell lysates were immunoprecipitated with anti-HA
monoclonal antibody (Sigma). The beads were washed 5 times
with lysis buffer and incubated with AcTEV protease (Invitrogen)
in 0.1 ml of lysis buffer at 4uC for overnight. All samples were
analyzed by Western blotting.
Western Blotting
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophore-
sis analysis was carried out using NuPAGE Novex gels (Invitro-
gen), and the proteins were transferred onto PVDF membranes
(Invitrogen), followed by blocking with 5% skim milk for 1 h, and
an incubation with primary antibodies overnight at 4uC. The
membranes were washed with TBST (25 mM Tris, pH 7.4,
150 mM NaCl, 2 mM KCl and 0.01% Tween 20), and incubated
with anti-rabbit or mouse IgG horseradish peroxidase-conjugated
antibodies (GE Healthcare) for 1 h at room temperature, and then
washed with TBST buffer. Immunoreactive proteins were
visualized using an enhanced chemiluminescence detection system
(Pierce Biotechnology, Rockford, IL, USA).
Isolation of Mitochondria and SelO Localization
Mitochondria were isolated from the HEK293T cells transfect-
ed with wild type (CxxU) SelO constructs. Forty eight hours after
transfection, cells were collected and washed two times with PBS,
and then homogenized with Dounce homogenizer in extraction
buffer (10 mM HEPES, pH 7.5, 200 mM mannitol, 70 mM
sucrose, 1 mM EGTA, and 2 mg/ml BSA) containing protease
inhibitor (Roche) and 20 mM N-ethylmaleimide. The homogenate
was centrifuged at 600 g for 10 min and the supernatant was
further centrifuged at 11,000 g for 10 min. The supernatant was
the cytosolic fraction. The pellet was resuspended in extraction
buffer without BSA and centrifuged at 600 g for 10 min. Then,
the supernatant was re-centrifuged at 11,000 g for 10 min. Finally,
the pellet was the mitochondrial fraction. The isolated fractions
were examined for purity by Western blotting using several
organelle-specific antibodies. The mitochondrial marker antibody
was thioredoxin reductase 2 (TR2; also known as Thioredoxin
reductase TR3) and cytosolic marker antibodies were thioredoxin
reductase 1 (TR1) and tubulin antibodies.
The SelO ORF was cloned into pEGFP-N1 vector (Clontech,
Palo Alto, CA, USA) to confirm subcellular localization of SelO.
The SelO construct was transfected into HEK293T cells. After
48 h, cells were washed with PBS and stained with Mito-Tracker
Red (Molecular Probes, Eugene, OR, USA) for 15 min at a final
concentration of 50 nM. The cells were washed three times with
PBS and fixed with 10% paraformaldehyde for 15 min. After
staining, EGFP and Mito-Tracker fluorescence were visualized
using a confocal LSM 700 microscope (Carl Zeiss, Oberkochen,
Germany).
Figure 2. Redox interactions involing human SelO. (A) Protein sequence alignment of the C-terminal region of SelO. (B) Recombinant SelOs.
The plasmid construct was designed to trap the interacting partner. The mitochondrial leader sequence (MLS) was flanked by the HA-TEV sequence
and the CXXU was changed to SXXU, CXXC, SXXC, CXXS, or SXXS. (C–D) Western blotting of SelO with (C) the cell lysates or (D) the samples that were
prepared by using immunoprecipitation with anti-HA antibody from HEK293T cells expressing recombinant human SelO or its mutant forms (CXXU,
CXXC, CXXS, SXXU, SXXC, SXXS).
doi:10.1371/journal.pone.0095518.g002
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Results and Discussion
SelO Localizes to Mitochondria
Among the 25 mammalian selenoproteins, only two selenopro-
teins, TR2 and glutathione peroxidase 4 (GPX4), were shown to
reside in mitochondria with function in regulation of mitochon-
drial redox homeostasis [10,23]. The presence of a mitochondrial
leader sequence (MLS) in SelO (Fig. 1A) suggested it localizes to
mitochondria. We prepared cytosolic and mitochondrial fractions
of HEK293T cells and examined them by Western blotting
(Fig. 1B). We confirmed the purity of cellular fractions by
analyzing proteins known to reside in the cytosol and mitochon-
dria. SelO was found exclusively in the mitochondrial fraction,
indicating its localization in this compartment. To further verify its
mitochondrial localization, we assayed intracellular SelO locali-
zation using the recombinant human GFP-fused SelO containing
Cys in the place of Sec at its C-terminal end (Fig. 1A). EGFP
(Green) and Mito-Tracker (Red) co-localization confirmed that
SelO localized to mitochondria (Fig. 1C). Taken together, these
results demonstrate that SelO is targeted to mitochondria in
mammals.
Redox Interactions of SelO
Most of the functionally characterized selenoproteins are
oxidoreductases that contribute to various redox functions in
biological systems [11]. The occurance of the CXXU (with Cys664
and Sec667 separated by two other residues) motif in human SelO
suggested that, like other selenoproteins, SelO may have redox
activity. The CXXU motif is conserved across a broad range of
organisms in the form of either the CXXU or the CXXC motif
(although some of the more distant sequences lack the Cys in the
motif), suggesting that Sec and Cys in the CXXU motif may act as
catalytic and resolving residues (Fig. 2A). Identifying a redox target
protein interacting with the conserved CXXU motif can be crucial
in understanding the role of SelO as a redox-active protein To test
this, we prepared recombinant human SelO in which the CXXU
motif was mutated to CXXC, CXXS, SXXU, SXXC, or SXXS
and a HA-TEV tag was flanked by upstream MLS and itself
upstream of SelO (Fig. 2B). These recombinant proteins were
expressed in HEK293T cells, which were treated with H2O2, and
the cell lysates were prepared for Western blotting or subjected to
immunoprecipitation with HA-specific antibodies. We then
liberated SelO by using TEV protease-mediated cleavage that
Figure 3. Effect of hydrogen peroxide on redox interactions involving SelO. (A) 0, 0.25, 0.5, 0.75, 1, or 2 mM hydrogen peroxide was added
for 5 min to HEK293T cells expressing recombinant human SelO proteins containing either SXXC or SXXS. (B) 0.75 mM hydrogen peroxide was added
to HEK293T cells expressing recombinant human SelO proteins containing either SXXC or SXXS motifs for 5, 10, 30, 60, or 120 min. Then, all cell
lysates were subjected to Western blotting with anti-SelO antibodies under reducing or non-reducing condition.
doi:10.1371/journal.pone.0095518.g003
Redox-Active Mitochondrial Selenoprotein O
PLOS ONE | www.plosone.org 4 April 2014 | Volume 9 | Issue 4 | e95518
removed the N-terminal MLS-HA-TEV sequence and associated
proteins. Finally, the cell lysates or the resulting SelO protein
complex was subjected to Western blotting using anti-SelO
antibody under reducing and non-reducing conditions (Fig. 2C,
D). One band (,88 kDa) appeared only in the SXXC and CXXC
samples under non-reducing conditions and the abundance of this
88 kDa protein complex was greater in the case of SXXC than the
CXXC motif. This result strongly supported the existence of a
potential redox target protein of SelO because the SXXC motif, in
which the potential resolving Cys was replaced with Ser, enabled
the mutant SelO to trap a redox target protein, whereas Ser
substitution of the potential catalytic Cys (e.g., SXXS and CXXS
motifs) prevented the formation of an interprotein disulfide bond.
We further examined the effect of varying H2O2 concentrations
and incubation times on the formation of the 88 kDa protein
complex involving SXXC and SXXS mutant forms of SelO. The
88 kDa complex was detected for the SXXC form of SelO upon
hydrogen peroxide treatment, but not in the case of SXXS
(Fig. 3A). Moreover, the target protein disappeared with an
increase in incubation times. These experiments provide evidence
that human SelO interacts with a target protein in a redox
manner, through the conserved CXXU motif. This interaction is
reversible and depends on hydrogen peroxide treatment, repre-
senting a typical property of thiol-dependent oxidoreduction.
Confirmation of Sec Incorporation into Full-length SelO
A study that discovered SelO as one of 25 mammalian
selenoproteins also provided support for 75Se incorporation into
these proteins, including a truncated form of SelO [6]. The full-
length SelO, however, was not examined. Following 75Se
metabolic labeling of HEK293T cells, SelO was immunoprecip-
itated with the SelO antibody and analyzed by phosphorimaging
and Western blotting (Fig. 4A–C). The SelO band was detected by
both methods, indicating that the endogenous SelO contains Sec.
We further examined Sec incorporation into recombinant SelO
proteins containing CXXU and the CXXS motifs. Following 75Se
metabolic labeling, the recombinant SelO proteins were immu-
noprecipitated with the antibody to HA-tag and subjected to
phosphorimaging and Western blotting. Both recombinant SelO
forms were detected on Western blotting, but only the CXXU
protein was detected by phosphorimaing (Fig. 4D–F). Taken
together, these data show that the full-length SelO contains Sec in
the C-terminal region.
Figure 4. Incorporation of selenium into mammalian SelO. Endogenous SelO was metabolically labeled with 75Se in HEK293T cells. Cell lysate
was immunoprecipitated with anti-SelO antibody and visualized by (A) phosphorimaging and (B) Western blotting with anti-HA antibody. (C) Amido
black staining shows equal loading. The 75Se labeled cell lysate was also immunoprecipitated with anti-HA antibody. SelO in this sample was
visualized by (D) phosphorimaging and (E) Western blotting with anti-SelO antibody. (F) Amido black solution was used to stain the membrane for
loading control.
doi:10.1371/journal.pone.0095518.g004
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Regulation of SelO Expression by Dietary Selenium
Priority for Se supply in synthesizing selenoproteins is repre-
sented by hierarchy in selenoprotein expression upon selenium
deficiency [24,25]. For instance, dietary selenium deficiency
dramatically reduces the expression of GPX1 and MsrB1 in mice,
whereas the expression of TR1, TR2, and GPX4 is largely
preserved under these conditions. Although the mechanism of this
regulation is multifactorial and incompletely understood, reports
point out the importance of the SECIS type in regulation of
selenoprotein expression. For example, eIF4a3 was recently found
to bind type 1 SECIS in GPX1 mRNA, whereas it did not interact
with type 2 SECIS in GPX4 mRNA [24]. By using the
SECISearch, we visualized SECIS structures in mouse SelO
(COVE score: 22.22) and MsrB1 (COVE score: 23.75) (Fig. 5A).
Interestingly, mouse SelO contains type 2 SECIS. We examined
how the expression of SelO is regulated by dietary selenium. We
carried out Western blotting of SelO, MsrB1, and b-actin in the
liver lysates prepared from mice raised on various selenium diets
(Fig. 5BCD). As expected, MsrB1 expression was dramatically
reduced (i.e., more than 10 fold) by selenium deficiency diet
(0?ppm). On the other hand, SelO expression under these
conditions was not reduced as much (i.e., less than 2 fold). Thus,
SelO can be classified as a selenoprotein with high priority for
selenium supply.
It was recently hypothesized that SelO may have a kinase
function, based on functional and structural prediction of its
structure [19,20]. These predictions require experimental verifi-
cation. We demonstrate here that SelO is a mitochondrial
selenoprotein engaged in redox interaction with an unknown
protein through its CXXU motif. Redox regulation of protein
function in mitochondria may involve kinase functions. For
example, mitochondrial oxidation of ERK at Cys38 and Cys214
or AKT at Cys60 and Cys310 regulates kinase activity and signaling
cascades [26]. It would be interesting to determine the identity of
the SelO target protein, which may lead to direct functional
insights for this protein.
Supporting Information
Table S1 PCR primers used in cloning and preparation of
chimeric gene expression constructs.
(DOCX)
Figure 5. Regulation of SelO expression by dietary selenium. (A) Sec insertion sequence (SECIS) structure of mouse SelO and MsrB1. (B)
Western blotting of SelO, MsrB1, and b-actin in liver lysates. Mice were fed various selenium diets (0, 0.1, 0.4, and 2.25 ppm) for 8 weeks. Expression
ratio of (C) SelO to b-actin and (D) MsrB1 to b-actin. All quantifications were performed by using the Image J program.
doi:10.1371/journal.pone.0095518.g005
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